Evercore ISI analyst Vijay Kumar lowered the firm’s price target on Illumina (ILMN) to $180 from $184 and keeps an Outperform rating on the shares. In the firm’s 2025 outlook note for MedTech ...

The "Tumor Profiling Market by Technique, by Technology, by Application, by End-User, and By Region" report has been added to ...

The simplest way to install SpliceAI is through pip or conda: ...

After hours: 3 January at 19:53:14 GMT-5 ...

ILMN.

After hours: January 3 at 7:53:14 p.m. EST ...

GEN uncovers seven biopharma-related trends based on interviews with experts and other industry stakeholders, as well as ...

ClariMed, Inc., a global leader in human-centered medical device development and regulatory services, has announced the ...